Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSA | P10619 | 10/20 | 0.42 |
| ▸ | ITGB3 | P05106 | 4/20 | 0.38 |
| ▸ | ITGAV | P06756 | 4/20 | 0.38 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL687697 | 0.82 | CTSA (0.40) | CTSACYP3A4CYP2D6CYP2C19P2RX3 | |
| SCHEMBL687209 | 0.80 | CYP2C19 (0.50) | CTSACYP3A4CYP2D6CYP2C19MEN1 | |
| SCHEMBL686970 | 0.77 | CTSA (0.42) | CTSA | |
| SCHEMBL688412 | 0.77 | ALDH1A1 (0.47) | CTSARXFP1 | |
| SCHEMBL687355 | 0.75 | CTSA (0.40) | CTSA | |
| SCHEMBL13120819 | 0.74 | MAPT (0.40) | P2RX3MEN1KMT2A | |
| SCHEMBL687794 | 0.73 | MEN1 (0.45) | CTSACYP2C19MEN1KMT2A | |
| SCHEMBL7383966 | 0.72 | CTSA (0.47) | CTSARXFP1 | |
| SCHEMBL688110 | 0.72 | MEN1 (0.49) | CTSACYP2C19MEN1KMT2A | |
| SCHEMBL686852 | 0.72 | PPARG (0.38) | CTSAITGB3ITGAVMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1203766-B1 | Carboxylic acid derivatives that inhibit the binding of integrins to their receptors | ENCYSIVE PHARMACEUTICALS INC (US) | 2012-02-29 | — | — | EP | disclosed |
| EP-1176956-B1 | CARBOXYLIC ACID DERIVATIVES THAT INHIBIT THE BINDING OF INTEGRINS TO THEIR RECEPTORS | ENCYSIVE PHARMACEUTICALS INC (US) | 2008-01-09 | — | — | EP | disclosed |
| EP-1203766-A2 | Carboxylic acid derivatives that inhibit the binding of integrins to their receptors | TEXAS BIOTECHNOLOGY CORPORATION (US) | 2002-05-08 | — | — | EP | disclosed |